Latest On ResMed Inc (RSMDF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 05:57 EST | Dividend | A dividend of $0.07 has been announced on Apr 28, 2023. It will be paid Jun 15, 2023 with an ex-dividend date of May 10, 2023. | Neutral |  |
| 2023-04-28 01:22 EST | News | ResMed Inc. 2023 Q3 - Results - Earnings Call Presentation | N/A | |
| 2023-04-28 01:22 EST | News | ResMed Inc. (RMD) Q3 2023 Earnings Call Transcript | N/A | |
| 2023-01-27 03:10 EST | News | ResMed Inc. 2023 Q2 - Results - Earnings Call Presentation | N/A | |
| 2023-01-27 03:10 EST | News | ResMed Inc. (RMD) Q2 2023 Earnings Call Transcript | N/A | |
| 2022-10-28 08:48 EST | News | ResMed Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-10-28 08:48 EST | News | ResMed Inc. (RMD) Q1 2023 Results - Earnings Call Transcript | N/A | |
| 2022-08-29 21:37 EST | News | ResMed: Long-Term Thesis Remains Unchanged, Rate Buy For Compelling Value | N/A | |
| 2022-08-17 05:58 EST | Dividend | A dividend of $0.06 has been announced on Aug 12, 2022. It will be paid Sep 22, 2022 with an ex-dividend date of Aug 17, 2022. | Neutral | |
| 2022-08-12 11:15 EST | News | ResMed Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-08-12 11:15 EST | News | Resmed, Inc. (RMD) CEO Michael Farrell on Q4 2022 Results - Earnings Call Transcript | N/A | |
| 2022-06-17 22:48 EST | News | ResMed (RMD) Presents On Acquisition Of MedifoxDan - Slideshow | N/A | |
| 2022-05-11 05:57 EST | Dividend | A dividend of $0.06 has been announced on Apr 29, 2022. It will be paid Jun 16, 2022 with an ex-dividend date of May 11, 2022. | Neutral | |
| 2022-04-29 16:25 EST | News | ResMed Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-04-28 23:18 EST | News | ResMed Inc. (RMD) CEO Mick Farrell on Q3 2022 Results - Earnings Call Transcript | N/A | |
| 2022-02-09 04:58 EST | Dividend | A dividend of $0.06 has been announced on Jan 28, 2022. It will be paid Mar 17, 2022 with an ex-dividend date of Feb 9, 2022. | Neutral | |
| 2022-01-28 00:02 EST | News | ResMed Inc. (RMD) CEO Mick Farrell on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-01-24 13:35 EST | News | ResMed (RMD) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2021-11-10 04:59 EST | Dividend | A dividend of $0.06 has been announced on Oct 29, 2021. It will be paid Dec 16, 2021 with an ex-dividend date of Nov 10, 2021. | Neutral | |
| 2021-10-29 10:01 EST | News | ResMed Inc. (RMD) CEO Mick Farrell on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2021-09-11 07:40 EST | News | ResMed (RMD) Investor Presentation - Slideshow | N/A | |
| 2021-08-18 05:59 EST | Dividend | A dividend of $0.06 has been announced on Aug 6, 2021. It will be paid Sep 23, 2021 with an ex-dividend date of Aug 18, 2021. | Neutral | |
| 2021-08-06 14:46 EST | News | ResMed Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-08-06 14:46 EST | News | ResMed Inc. (RMD) CEO Mick Farrell on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-12 06:00 EST | Dividend | A dividend of $0.05 has been announced on Apr 30, 2021. It will be paid Jun 17, 2021 with an ex-dividend date of May 12, 2021. | Neutral | |
| 2021-04-30 23:16 EST | News | ResMed Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-04-30 01:17 EST | News | ResMed Inc. (RMD) CEO Mick Farrell on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-01-30 09:05 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-29 10:00 EST | News | ResMed Inc. (RMD) CEO Mick Farrell on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-01-29 10:00 EST | News | ResMed Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-01-21 02:38 EST | News | ResMed(RMD) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2020-11-26 22:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 10:59 EST | News | ResMed's Double-Digit Operating Leverage Is Offset By Valuation Risk | N/A | |
| 2020-11-10 04:59 EST | Dividend | A dividend of $0.06 has been announced on Oct 30, 2020. It will be paid Dec 17, 2020 with an ex-dividend date of Nov 10, 2020. | Neutral | |
| 2020-11-08 01:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 09:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 07:57 EST | News | ResMed's (RMD) CEO Mick Farrell on Q1 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-01 07:57 EST | News | ResMed Inc. 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2020-09-26 14:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 07:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 10:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 06:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 04:30 EST | News | ResMed Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2020-08-06 04:30 EST | News | ResMed, Inc. (RMD) CEO Mick Farrell on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2020-07-30 18:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:51 EST | Financials | Company financials have been released. | Neutral | |
About ResMed Inc (RSMDF):
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
General
- Name ResMed Inc
- Symbol RSMDF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 7,770
- Last Split Factor2:1
- Last Split Date2010-08-31
- Fiscal Year EndJune
- Web URLhttp://www.resmed.com
Valuation
- Trailing PE 38.32
- Forward PE 35.09
- Price/Sales (Trailing 12 Mt.) 8.67
- Price/Book (Most Recent Quarter) 9.32
- Enterprise Value Revenue 9.02
- Enterprise Value EBITDA 26.5
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 23%
- Operating Margin 29%
- Return on Assets 13%
- Return on Equity 27%
- Revenue 3.09 billion
- Earnings Per Share $0.48
- Revenue Per Share $2.13
- Gross Profit 1.77 billion
- Quarterly Earnings Growth 8.7%
Highlights
- Market Capitalization 27.86 billion
- EBITDA 1.01 billion
- PE Ratio 33.25
- PEG Ratio 4.34
- Analyst Target Price $11.49
- Book Value Per Share $1.97
Share Statistics
- Shares Outstanding 1.46 billion
- Shares Float 1.43 billion
- % Held by Insiders <1%
- % Held by Institutions 9.01%
Technicals
- Beta 0.31
- 52 Week High $21.51
- 52 Week Low $12.05
- 50 Day Moving Average 19.86
- 200 Day Moving Average 19.46
Dividends
- Forward Annual Dividend Rate $0.16
- Forward Annual Dividend Yield 0.85%
- Payout Ratio 4%
- Dividend Date N/A
- ExDividend Date 2021-02-10
- Dividend Per Share $1.56
- Dividend Yield 0%
ResMed Inc (RSMDF) Dividend Calendar:
ResMed Inc pays out 4% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
ResMed Inc (RSMDF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $N/A | $1.23 | $0.00 | |
| 2020-06-30 | 2020-09-30 | $N/A | $1.22 | $0.12 | 916.67% |
| 2020-03-31 | 2020-06-30 | $N/A | $1.22 | $0.10 | 1121.6% |
| 2019-12-31 | 2020-03-31 | $736.16 million | $1.12 | $0.28 | 300% |
| 2019-09-30 | 2019-12-31 | $681.06 million | $1.10 | $0.24 | 358.33% |
| 2019-06-30 | 2019-09-30 | $704.96 million | $0.83 | $0.09 | 822.22% |
| 2019-03-31 | 2019-06-30 | $662.23 million | $0.47 | $0.09 | 424% |
| 2018-12-31 | 2019-03-31 | $651.1 million | $0.73 | $0.09 | 711.11% |
| 2018-09-30 | 2018-12-31 | $588.28 million | $0.86 | $0.08 | 975% |
| 2018-06-30 | 2018-09-30 | $623.63 million | $0.73 | $0.11 | 563.64% |
| 2018-03-31 | 2018-06-30 | $5.59 million | $0.76 | $0.08 | 851% |
| 2017-12-31 | 2018-03-31 | $5.34 million | $0.76 | $0.07 | 985.71% |
| 2017-09-30 | 2017-12-31 | $4.64 million | $0.07 | $0.06 | 11.33% |
| 2017-06-30 | 2017-09-30 | $556.69 million | $0.60 | $0.07 | 757.14% |
| 2017-03-31 | 2017-06-30 | $0.71 | $0.07 | 911.14% | |
| 2016-12-31 | 2017-03-31 | $0.62 | $0.06 | 932.83% | |
| 2016-09-30 | 2016-12-31 | $0.54 | $0.06 | 800% | |
| 2016-06-30 | 2016-09-30 | $0.54 | $0.07 | 671.43% | |
| 2016-03-31 | 2016-06-30 | $0.59 | $0.07 | 743% | |
| 2015-12-31 | 2016-03-31 | $0.64 | $0.06 | 966.67% | |
| 2015-09-30 | 2015-12-31 | $0.68 | $0.06 | 1033.33% | |
| 2015-06-30 | 2015-09-30 | $0.58 | $0.06 | 866.67% | |
| 2015-03-31 | 2015-06-30 | $0.61 | $0.07 | 772.71% | |
| 2014-12-31 | 2015-03-31 | $0.64 | $0.06 | 966.67% | |
| 2014-09-30 | 2014-12-31 | $0.64 | $0.06 | 966.67% | |
| 2014-06-30 | 2014-09-30 | $0.58 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.61 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.63 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.60 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.56 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.50 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.58 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.53 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.49 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.53 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.44 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.42 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.33 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.37 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.34 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.37 | $0.00 |
ResMed Inc (RSMDF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
ResMed Inc (RSMDF) Chart:
ResMed Inc (RSMDF) News:
Below you will find a list of latest news for ResMed Inc (RSMDF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ResMed Inc (RSMDF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
ResMed Inc (RSMDF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|